The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination - Wikidata - thesis-toulmin - TriplyDB

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

http://www.wikidata.org/entity/Q28265780

about

The reticulons: a family of proteins with diverse functions Nogo limits neural plasticity and recovery from injury Nogo receptor inhibition enhances functional recovery following lysolecithin-induced demyelination in mouse optic chiasm Astrocytes in multiple sclerosis: a product of their environment Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcome Developing therapeutics for the treatment of multiple sclerosis Nogo-A expression in the brain of mice with cerebral malaria Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.Amyotrophic lateral sclerosis: a focus on disease progression Silencing Nogo-A promotes functional recovery in demyelinating disease.Niacin treatment of stroke increases synaptic plasticity and axon growth in rats.Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.Overexpression of glia maturation factor reinstates susceptibility to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in glia maturation factor deficient mice.Proteolytic control of neurite outgrowth inhibitor NOGO-A by the cAMP/PKA pathway.Nogo-receptor 1 deficiency has no influence on immune cell repertoire or function during experimental autoimmune encephalomyelitis.Emerging therapies for treatment of multiple sclerosis Discovery, optimization, and pharmacological characterization of novel heteroaroylphenylureas antagonists of C-C chemokine ligand 2 function The axon-glia unit in white matter stroke: mechanisms of damage and recovery.Thymic gene transfer of myelin oligodendrocyte glycoprotein ameliorates the onset but not the progression of autoimmune demyelination.Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.Therapeutic benefit of treatment of stroke with simvastatin and human umbilical cord blood cells: neurogenesis, synaptic plasticity, and axon growth The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease.Therapeutic vaccination for central nervous system repair.Toward biomarkers in multiple sclerosis: new advances.Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.Diabetes-induced central neuritic dystrophy and cognitive deficits are associated with the formation of oligomeric reticulon-3 via oxidative stress.Delayed administration of a PTEN inhibitor BPV improves functional recovery after experimental stroke Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology.Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis.MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis."Opening" the mesenchymal stem cell tool box.Axonal degeneration as a therapeutic target in the CNS.Multiple sclerosis: does Nogo play a role?New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis.The role of reticulons in neurodegenerative diseases.CRMP2: functional roles in neural development and therapeutic potential in neurological diseases.

P2860

Q21184131-9D1ADAC2-C9E0-4F13-A943-72A12208FEA4 Q26861883-35EDB03A-DF8A-4787-BB31-0381F16EA874 Q27313149-24B0917C-DF01-479E-8B30-443CB13F078E Q28282324-06C96FF2-98C3-4B16-AAAB-C725E1D2D251 Q28742885-74097E14-04DE-420C-907C-99079959462E Q33767902-B60BE5A0-5836-47ED-946F-3CC21079F3D5 Q33851008-9300B61B-66B3-4EA7-B9B7-C824F68FCA7F Q33862545-7540A772-D034-403A-A289-967364073836 Q33912735-074936ED-6F8C-4E60-A794-C56686C6A981 Q33946995-347B2E86-7E8A-409C-B2CF-48A1461ECF65 Q34043486-1DD14289-1669-4B6C-B8DD-44B08840C885 Q34055604-9AAF4AC4-DFBB-4AE5-A784-0E63F47FD912 Q34064143-B4B73D48-CE54-41B2-9308-ADB41C074E0E Q34089956-84ADF0EA-2582-462F-96BD-0E3394B51CF8 Q34101292-01773526-E011-46EC-B500-3199097218F6 Q34109028-72A88009-A6DC-48F1-8CDC-142EE81B9AEF Q34203780-630F46B9-7C80-4CA8-A33B-EDC1745E5D13 Q34480691-A0F75A96-5BC1-47E0-ABCC-A5EED4C8FF0A Q35067696-62823A08-26EC-4B71-8474-8FB3E7F14D55 Q35557390-90B4CDA1-DF3F-4F84-8902-CA6686C64DBE Q35588337-EA30E2DB-F4ED-4368-A5C4-55F473AC8199 Q35984483-24CCC807-AFDE-4429-B00A-FF43E12B41FA Q36085377-02C2A949-D695-4F20-B397-EC322576737A Q36187725-6D50729A-D9E8-4B0B-950C-83446AE98A04 Q36235193-841A0D39-1284-4619-9622-A4760BADA2E5 Q36267176-5947D270-9978-4A50-8AC5-1B2E34578068 Q36478853-EA583A95-5ED4-4C1F-8059-04D05708F837 Q36492380-511A9081-1A54-4EE6-868F-0F510C8294E7 Q36661334-29A5EAA2-EA09-455B-889C-77FDDB2FC12D Q36890582-59F08786-DBFA-4DAE-A051-73E7658BAA0B Q36951450-54108B3D-7FB7-4C83-9964-B64F58EF878C Q36973566-B5250643-0EAB-4A3A-981E-F09ADE266453 Q37141293-BF09669A-A867-4E85-B275-A1C140358416 Q37315208-465E0A01-51EC-44D4-866E-8D6B6DA28164 Q37597894-91BC5089-D499-4CCD-A655-5E187C93A39D Q37990880-2655890F-5493-4379-84BB-C9FE967E7C8C Q38082999-44E5AA2A-E113-4CC9-856A-9D5DF6CEAEF8 Q38103283-43147EB0-1A0C-499E-9D5F-4276C9F8A053 Q38161870-92D12D47-B3F5-4250-B91F-59CF7E730A50 Q38176810-EFF91744-9F5E-4502-9799-67EB16CD228B

P2860

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

http://www.wikidata.org/entity/Q28265780

description

2004 nî lūn-bûn

@nan

2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

@ast

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

@en

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

@nl

type

label

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

@ast

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

@en

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

@nl

prefLabel

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

@ast

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

@en

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

@nl

P1433

Q28265780-6A5DB58D-02B8-47F3-9A93-4CD30F7FB6AB

P1476

Q28265780-9EB221EE-F55E-4D40-B163-C91C844F6EE7

P2093

Q28265780-0637A5EA-9233-4424-BAAE-9CEE3A995829

Q28265780-1D3D3C80-B496-4121-96F2-7B33487A9BAC

Q28265780-4E743F81-5352-427F-8B34-FA2E69C8453B

Q28265780-64632E3B-CEBA-4001-9D2B-55C150E9E04B

Q28265780-8B57EB41-A6D4-4512-B80E-FD7069FC722F

Q28265780-BCE6F331-AA09-4BF9-BD8D-032B9C66C682

Q28265780-C1F423F6-E877-4360-8501-930BFA13B15B

Q28265780-F418B6C9-DAB6-4F00-9E59-033B1F885D96

Q28265780-FC340B16-E354-4BD8-9196-C17F055889C1

P2860

Q28265780-2AD10B62-0908-4D41-B438-971E4B7E6D78

Q28265780-2D744876-0E70-4DBE-A3AD-7D277269E84B

Q28265780-3274CE1F-CC80-47ED-84CF-35FBBC536EA2

Q28265780-36052FE6-A6AF-46F9-86FA-464DA1D85300

Q28265780-9925B746-61BE-430A-A291-37FA1B7F5401

Q28265780-B7E04498-3E04-4952-ACDB-7BC5F4120EFF

Q28265780-D723D7F6-C379-4462-BC15-5C6B32EA7D85

Q28265780-EB16FA61-BAB0-4D65-8364-5407C1E06DA8

Q28265780-F8211037-740B-476C-8423-05EEA71A56A7

P2888

Q28265780-0FD4CF8E-A856-41FE-BC75-90981D5A70B7

P304

Q28265780-538858BA-F9EE-4F6B-BE63-ABCE5817F0C0

P31

Q28265780-BB0DE688-DCA5-4B3D-AAF5-13070FB191CB

P356

Q28265780-12CB5200-B677-4176-8663-3BFFBBB13E15

P407

Q28265780-854859DE-489E-4149-AF2A-97AEFCAC7269

P433

Q28265780-0C4CDA45-F143-4AAC-8DC9-6B5D51CCFD08

P478

Q28265780-0C4AFBEA-48A8-462D-A7C4-239D59369085

P50

Q28265780-7DE9897C-6586-4EDA-9E40-D4E7291CD847

P577

Q28265780-B058CDDF-512C-410A-B3B7-2FB15760AF94

P5875

Q28265780-4B11638A-3205-46FB-AFEA-985DFE38A159

P698

Q28265780-6629A8E3-6164-4AEB-AD2F-38BA8AF7D0BC

P921

Q28265780-8623E86E-AA34-48AF-BAA1-360CEAEAA84B

P356

P1433

Nature Neuroscience

P1476

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

@en

P2093

Belinda M Murray

http://www.w3.org/2001/XMLSchema#string

Ben Barres

http://www.w3.org/2001/XMLSchema#string

Binhai Zheng

http://www.w3.org/2001/XMLSchema#string

Claude C A Bernard

http://www.w3.org/2001/XMLSchema#string

Jonathan L McQualter

http://www.w3.org/2001/XMLSchema#string

Kelly A Jordan

http://www.w3.org/2001/XMLSchema#string

Peggy P Ho

http://www.w3.org/2001/XMLSchema#string

Tara Karnezis

http://www.w3.org/2001/XMLSchema#string

Wim Mandemakers

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein

Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration

Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders

A new role for Nogo as a regulator of vascular remodeling

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

Nogo-66 receptor antagonist peptide promotes axonal regeneration

Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth

P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp

Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth

P2888

P304

736-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NN1261

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Marc Tessier-Lavigne

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8521983

http://www.w3.org/2001/XMLSchema#string

P698

15184901

http://www.w3.org/2001/XMLSchema#string

P921